Insulin infusion induces endothelin-1-dependent hypertension in rats

American Journal of Physiology. Endocrinology and Metabolism
C C JuanLow-Tone Ho

Abstract

We previously showed that chronic insulin infusion induces insulin resistance, hyperendothelinemia, and hypertension in rats (C. C. Juan, V. S. Fang, C. F. Kwok, J. C. Perng, Y. C. Chou, and L. T. Ho. Metabolism 48: 465-471, 1999). Endothelin-1 (ET-1), a potent vasoconstrictor, is suggested to play an important role in maintaining vascular tone and regulating blood pressure, and insulin increases ET-1 production in vivo and in vitro. In the present study, BQ-610, a selective endothelin A receptor antagonist, was used to examine the role of ET-1 in insulin-induced hypertension in rats. BQ-610 (0.7 mg/ml; 0.5 ml/kg body wt) or normal saline was given intraperitoneally two times daily for 25 days to groups of rats infused with either saline or insulin (2 U/day via sc-implanted osmotic pumps), and changes in plasma levels of insulin, glucose, and ET-1 and the systolic blood pressure were measured over the experimental period, whereas changes in insulin sensitivity were examined at the end of the experimental period. Plasma insulin and ET-1 levels were measured by RIA, plasma glucose levels using a glucose analyzer, systolic blood pressure by the tail-cuff method, and insulin sensitivity by an oral glucose tolerance test. Our studie...Continue Reading

References

Mar 1, 1992·American Journal of Hypertension·T HaakK H Usadel
Feb 1, 1992·Hypertension·T F LüscherZ H Yang
Oct 16, 1989·Biochemical and Biophysical Research Communications·Y T XuanW D Watkins
Jun 1, 1994·Hypertension·W P MeehanW Hsueh
Mar 1, 1993·The Journal of Clinical Endocrinology and Metabolism·S M Haffner
Dec 1, 1995·The American Journal of Physiology·S VermaJ H McNeill
Oct 23, 1996·Biochemical and Biophysical Research Communications·C C JuanL T Ho
Aug 1, 1997·Japanese Journal of Pharmacology·M SuzukiH Ikeda
May 8, 1999·American Journal of Hypertension·J M RicheyR N Bergman
Jun 15, 1999·Journal of Cardiovascular Pharmacology·K NakamuraM Nakagawa
Aug 13, 1999·Methods and Findings in Experimental and Clinical Pharmacology·L Somova, M L Channa
Apr 11, 2000·Journal of Molecular and Cellular Cardiology·L PiacentiniJ S Karliner
Feb 13, 2001·American Journal of Physiology. Heart and Circulatory Physiology·P V KatakamA W Miller
Jun 20, 2001·American Journal of Hypertension·E L Schiffrin
Oct 20, 2001·Diabetes Research and Clinical Practice·I N MigdalisC Cordopatis
Feb 15, 2002·Diabetes, Obesity & Metabolism·Gerald M Reaven
Apr 6, 2002·American Journal of Physiology. Endocrinology and Metabolism·Yoshio NagaiAtsunori Kashiwagi
Jul 10, 2002·Hypertension·Allison W MillerDavid W Busija
Nov 21, 2002·American Journal of Hypertension·Jochen G SchneiderChristian Kasperk
Dec 31, 2002·Journal of Molecular and Cellular Cardiology·Peter ZahradkaShawn Thomas
Mar 19, 2003·Current Hypertension Reports·Marc Iglarz, Ernesto L Schiffrin
Mar 20, 2003·Current Diabetes Reports·C DesouzaV Fonseca
Mar 20, 2003·Current Diabetes Reports·James B Meigs

❮ Previous
Next ❯

Citations

Oct 21, 2011·Cardiovascular Research·Xiao-Bing CuiLi-Ling Wu
Jun 24, 2014·European Journal of Pharmacology·Suzanne A Nasser, Mahmoud M El-Mas
Aug 6, 2013·Current Hypertension Reports·Rebecca C MoorhouseNeeraj Dhaun
Apr 1, 2015·Biochemical and Biophysical Research Communications·Yan-Jie LinLow-Tone Ho
Sep 27, 2005·Medical Hypotheses·William T Phillips
Mar 25, 2008·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Tomoyasu FukuiMitsuru Adachi
Aug 28, 2007·The Veterinary Journal·Katie E AsplinCatherine M McGowan
Aug 5, 2014·Biochemical and Biophysical Research Communications·Yan-Jie LinLow-Tone Ho
Apr 19, 2008·Reproductive Sciences·Shilla Chakrabarty, Manubai Nagamani
Jan 31, 2006·Journal of the Society for Gynecologic Investigation·Shilla ChakrabartyManubai Nagamani
Jul 24, 2008·Nature Clinical Practice. Nephrology·Matthias Barton
Nov 23, 2006·The Journal of Clinical Endocrinology and Metabolism·Pantelis A Sarafidis, George L Bakris
Feb 26, 2015·Journal of Hypertension·Alice Victoria Klein, Hosen Kiat
May 9, 2006·Journal of the American Veterinary Medical Association·Kibby H TreiberW Burton Staniar
Jun 19, 2009·Molecular and Cellular Biochemistry·Linda T TranJohn H McNeill
May 1, 2020·Clinical and Experimental Hypertension : CHE·Hui WangGuangwei Li
Jun 15, 2006·The Journal of Nutrition·Kibby H TreiberRaymond J Geor

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.